Search Within

Taylor Wray Borrill

  1. "Advanced Practice Providers"
Formats
  1. Meeting Abstract (3)
  2. Journal Article (1)
Groups
  1. Advanced Practice Providers (4)
  2. Bone Marrow Transplant (4)
  3. Center for Hematologic Malignancies (4)
  4. Department of Medicine (4)
  5. Hematologic Malignancies, Division of (4)
  6. Survivorship Research (4)

More Groups

People
  1. Gunjan Shah (4)
  2. Miguel-Angel Perales (4)
  3. Elaina Preston (3)
  4. Kenneth Seier (3)
  5. Meighan Palazzo (3)
  6. Molly Maloy (3)

More People

Years
  1. 2024 (1)
  2. 2018 (2)
  3. 2017 (1)
Publications
  1. Biology of Blood and Marrow Transplantation (2)
  2. Bone Marrow Transplantation (2)
Publishers
  1. Elsevier Inc. (2)
  2. Nature Publishing Group (2)

Results (4)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Immune reconstitution, vaccine responses, and rituximab use after ex-vivo CD34-selected myeloablative allogenic hematopoietic cell transplantation
    Journal Article

    Melica, G.; Preston, E.; Palazzo, M.; Seier, K.; Malard, F.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Maslak, P.; more...
    Bone Marrow Transplantation (2024)

    Fulltext@MSK | Save
  • Disease progression is main barrier to allogeneic hematopoietic stem cell transplantation (HCT) in patients with newly diagnosed and relapsed acute leukemia
    Meeting Abstract

    Preston, E. V.; Chinapen, S.; Borrill, T.; Davis, E.; Shaffer, B. C.; Tamari, R.; Jakubowski, A. A.; Perales, M. A.; Ponce, D. M.; Shah, G. L.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Rituximab use, immune reconstitution, and vaccination after ex-vivo CD34-selected myeloablative allogeneic hematopoietic cell transplantation (HCT)
    Meeting Abstract

    Preston, E. V.; Malard, F.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; Smith, K.; Maslak, P.; more...
    Biology of Blood and Marrow Transplantation (2018)

    Fulltext@MSK | Save
  • Vaccines are safe and effective after T-cell depleted CD34-selected allogeneic hematopoietic stem cell transplantation (Allo HCT)
    Meeting Abstract

    Malard, F.; Shah, G. L.; Seier, K.; Cho, C.; Devlin, S. M.; Maloy, M.; Borrill, T.; Palazzo, M.; van den Brink, M.; Perales, M. A.
    Bone Marrow Transplantation (2017)

    Fulltext@MSK | Save